JP2024524215A5 - - Google Patents

Info

Publication number
JP2024524215A5
JP2024524215A5 JP2023578919A JP2023578919A JP2024524215A5 JP 2024524215 A5 JP2024524215 A5 JP 2024524215A5 JP 2023578919 A JP2023578919 A JP 2023578919A JP 2023578919 A JP2023578919 A JP 2023578919A JP 2024524215 A5 JP2024524215 A5 JP 2024524215A5
Authority
JP
Japan
Prior art keywords
group
protected
piperidine
groups
independently selected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023578919A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024524215A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/067126 external-priority patent/WO2022268935A2/en
Publication of JP2024524215A publication Critical patent/JP2024524215A/ja
Publication of JP2024524215A5 publication Critical patent/JP2024524215A5/ja
Pending legal-status Critical Current

Links

JP2023578919A 2021-06-23 2022-06-23 Nlrp3阻害剤を調製するための方法 Pending JP2024524215A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN202141028180 2021-06-23
IN202141028180 2021-06-23
PCT/EP2022/067126 WO2022268935A2 (en) 2021-06-23 2022-06-23 Novel process

Publications (2)

Publication Number Publication Date
JP2024524215A JP2024524215A (ja) 2024-07-05
JP2024524215A5 true JP2024524215A5 (cg-RX-API-DMAC7.html) 2025-06-27

Family

ID=82458485

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023578919A Pending JP2024524215A (ja) 2021-06-23 2022-06-23 Nlrp3阻害剤を調製するための方法

Country Status (12)

Country Link
US (1) US20240150291A1 (cg-RX-API-DMAC7.html)
EP (1) EP4359385A2 (cg-RX-API-DMAC7.html)
JP (1) JP2024524215A (cg-RX-API-DMAC7.html)
KR (1) KR20240024842A (cg-RX-API-DMAC7.html)
CN (1) CN118019727A (cg-RX-API-DMAC7.html)
AR (1) AR126215A1 (cg-RX-API-DMAC7.html)
AU (1) AU2022300325A1 (cg-RX-API-DMAC7.html)
CA (1) CA3219597A1 (cg-RX-API-DMAC7.html)
IL (1) IL308071A (cg-RX-API-DMAC7.html)
MX (1) MX2023014547A (cg-RX-API-DMAC7.html)
TW (1) TW202317514A (cg-RX-API-DMAC7.html)
WO (1) WO2022268935A2 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240148839A (ko) * 2022-02-15 2024-10-11 에프. 호프만-라 로슈 아게 1,2,3,5,6,7-헥사히드로-s-인다센 유도체 제조를 위한 공정
EP4638422A1 (en) * 2022-12-23 2025-10-29 F. Hoffmann-La Roche AG Proccesses for the preparation of an nlrp3 inhibitor
WO2025036914A1 (en) 2023-08-16 2025-02-20 F. Hoffmann-La Roche Ag Process for the preparation of preparing 1-ethyl-n-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)piperidine-4-sulfonamide
TW202545527A (zh) 2024-01-16 2025-12-01 英商諾得瑟拉公司 Nlrp3及glp-1a組合療法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA917435B (en) * 1990-09-26 1992-05-27 Takeda Chemical Industries Ltd Herbicides
CA2059450A1 (en) * 1991-01-24 1992-07-25 Nobuyuki Sakashita Subsituted pyridinesulfonamide compound or its salt, process for preparing the same, and herbicide containing the same
EP0981526B1 (en) * 1997-05-02 2004-02-25 Dr. Reddy's Laboratories Ltd. Novel antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
DK1340757T3 (da) * 2000-11-16 2007-02-12 Sankyo Co 1-methylcarbapenemderivater
EP1403255A4 (en) * 2001-06-12 2005-04-06 Sumitomo Pharma RHO KINASE INHIBITORS
CN100360130C (zh) * 2002-04-18 2008-01-09 先灵公司 用作组胺h3拮抗剂的1-(4-哌啶基)苯并咪唑酮
EP1677783A2 (en) * 2003-10-08 2006-07-12 Nicholas Piramal India Limited Fibrinogen receptor antagonists and their use
DOP2006000009A (es) * 2005-01-13 2006-08-15 Arena Pharm Inc Procedimiento para preparar eteres de pirazolo [3,4-d] pirimidina
ZA200904857B (en) * 2007-02-22 2010-09-29 Merck Serono Sa Quinoxaline compounds and use thereof
US20120196889A1 (en) * 2009-02-25 2012-08-02 H. Lundbeck A/S Catecholamine derivatives and prodrugs thereof
JP5898962B2 (ja) * 2012-01-11 2016-04-06 東京応化工業株式会社 レジスト組成物及びレジストパターン形成方法
WO2017095758A1 (en) * 2015-12-01 2017-06-08 Merck Sharp & Dohme Corp. Homobispiperidinyl derivatives as liver x receptor beta agonists, compositions, and their use
CN110914256A (zh) * 2017-07-07 2020-03-24 英夫拉索姆有限公司 新颖磺酰胺羧酰胺化合物
GB201712282D0 (en) * 2017-07-31 2017-09-13 Nodthera Ltd Selective inhibitors of NLRP3 inflammasome
TW201910314A (zh) * 2017-08-15 2019-03-16 愛爾蘭商英弗雷佐姆有限公司 新穎化合物
CN111902141A (zh) * 2018-03-26 2020-11-06 C4医药公司 用于ikaros降解的羟脑苷脂结合剂
CR20200588A (es) * 2018-05-04 2021-06-24 Inflazome Ltd Compuestos novedosos
CR20210148A (es) * 2018-09-21 2021-05-18 Novartis Ag Compuestos de isoxazol carboxamida y usos de los mismos
GB201817038D0 (en) 2018-10-19 2018-12-05 Inflazome Ltd Novel processes
GB201819083D0 (en) * 2018-11-23 2019-01-09 Inflazome Ltd Novel compounds
WO2020157069A1 (en) * 2019-01-28 2020-08-06 NodThera Limited Amino heterocyclic compounds and uses thereof
CN111393415B (zh) * 2020-04-30 2020-11-20 苏州信诺维医药科技有限公司 一种杂芳腈类化合物及其应用

Similar Documents

Publication Publication Date Title
JP2024099041A5 (cg-RX-API-DMAC7.html)
JP2014523916A (ja) N−置換環状アルキレン尿素を合成する方法
WO1998046231A1 (en) Muscarinic agonist compounds
JP4061018B2 (ja) ウレイドのn−アルキル化のための方法及び試薬
AU2010289802B2 (en) Synthesis of a neurostimulative piperazine
KR20160095161A (ko) 포스파티딜이노시톨 3-키나제 억제제의 가공 방법
Hazarika et al. Facile, catalyst-free cascade synthesis of sulfonyl guanidines via carbodiimide coupling with amines
KR102708701B1 (ko) 벤즈이미다졸 유도체의 제조방법
JP2002534409A5 (cg-RX-API-DMAC7.html)
JP2004517897A (ja) テモゾロミドおよびアナログの合成
CA2264298A1 (en) Catalytic selective sulfonylation process
JP2025506671A5 (cg-RX-API-DMAC7.html)
KR100538958B1 (ko) 4(5)-아미노-5(4)-카르복사미도이미다졸 및 그의 중간체의 제조방법
CN113087689A (zh) 5-氨基-γ-内酯衍生物的简便合成方法
RU2024101439A (ru) Новый способ
FI60704B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbar 2,6-dimetyl-3-metoxikarbonyl-4-(2'-nitrofenyl)-1,4-dihydropyridin-5-karboxylsyraisobutylester
US20040024217A1 (en) Synthesis of piperidine and piperazine compounds as CCR5 antagonists
US6730796B2 (en) Process for preparation of N-substituted 2-sulfanylimidazoles
JPWO2018043215A1 (ja) チオグリコールウリル類及びその製造方法
US3905992A (en) N,N{40 -alkylenebis(2-amino-1-(2-imidazolin-2-yl)-2-imidazolines)
US3278542A (en)
CN112409116B (zh) 一种胺基脂肪族硒氰酸酯类化合物的制备方法
KR101416077B1 (ko) 로듐 촉매를 이용한 분자간 탄소-질소 교차 짝지움 반응을 통한 아릴아민 화합물의 제조방법
CN102127031B (zh) 一种麻黄碱类化合物季胺盐及其合成方法和应用
RU2025120242A (ru) Способы получения ингибитора nlrp3